Roivant Sciences (ROIV) Receivables - Net (2021 - 2024)

Roivant Sciences (ROIV) posted Receivables - Net of $678000.0 for Q4 2024, down 64.61% on a QoQ basis from $1.9 million in Q3 2024, and down 98.35% year-over-year from $41.1 million in Q1 2024.

Roivant Sciences (ROIV) Receivables - Net (2021 - 2024) Analysis & Trends

Roivant Sciences' Receivables - Net history runs 4 years deep, the most recent figure standing at $678000.0 for Q4 2024.

  • Quarterly Receivables - Net fell 98.35% year-over-year to $678000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $678000.0 (down 98.35% YoY) and the FY2024 annual result came in at $678000.0, down 98.35% from the prior year.
  • Receivables - Net was $678000.0 for Q4 2024 at Roivant Sciences, down from $1.9 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $79.8 million in Q2 2024 and bottomed at $678000.0 in Q4 2024.
  • A 4-year average of $22.5 million and a median of $11.2 million in 2021 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2023 — Receivables - Net jumped 683.37% — and 2024, when it sank 98.35%.
  • Roivant Sciences' Receivables - Net stood at $8.9 million in 2021, then jumped by 213.5% to $28.0 million in 2022, then jumped by 46.88% to $41.1 million in 2023, then sank by 98.35% to $678000.0 in 2024.
  • Business Quant data shows ROIV's Receivables - Net at $678000.0 in Q4 2024, $1.9 million in Q3 2024, and $79.8 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Roivant Sciences 24.35 Bn 25.12 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2024 678,000.00
Dec 31, 2024 678,000.00
Sep 30, 2024 1.92 Mn
Sep 30, 2024 1.92 Mn
Jun 30, 2024 79.79 Mn
Jun 30, 2024 79.79 Mn
Mar 31, 2024 3.99 Mn
Mar 31, 2024 3.99 Mn
Dec 31, 2023 41.08 Mn
Dec 31, 2023 41.08 Mn
Sep 30, 2023 52.12 Mn
Sep 30, 2023 52.12 Mn
Jun 30, 2023 37.06 Mn
Jun 30, 2023 37.06 Mn
Mar 31, 2023 30.38 Mn
Mar 31, 2023 30.38 Mn
Dec 31, 2022 27.97 Mn
Dec 31, 2022 27.97 Mn
Sep 30, 2022 25.04 Mn
Sep 30, 2022 25.04 Mn